stars 1 stars 2 stars 3

Creo Pharma is a specialist pharmaceutical company dedicated to providing generic medicines, commercial brands and specialist supply products for the pharmacy, hospital and wholesale sector. We pride ourselves on being a highly flexible, professional team, providing the highest levels of service for our customers and suppliers. From 2013 until Creo Pharma Ltd. was a subsidiary of Amneal Pharmaceuticals Group. As of April 1st 2019 we became a part of Zentiva. Our core philosophy ensures that we keep our customers and supply partners at the heart of our business. We will expand our new products pipeline, offering our customers direct access to a growing range of innovative medicines and specialist generics. Our UK business focuses on two key areas: i) The commercial pharmaceutical arena, where we provide alternative brands and niche generics to fulfill open prescriptions. ii) Specific unlicensed and "off-label" products, direct to retail and hospital pharmacy, in addition to providing an out of hours emergency service for the supply of critical medicine. If you are interested in working with Creo Pharma to supply products in to the UK market, please contact bd@creopharma.com

Creo Pharma Questions

The Creo Pharma annual revenue was $7 million in 2026.

1 people are employed at Creo Pharma.

The NAICS codes for Creo Pharma are [32, 325, 3254, 32541].

The SIC codes for Creo Pharma are [28, 283, 2834].

Top Creo Pharma Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users